» Articles » PMID: 34523692

Transcription Factor HOXC10 Activates the Expression of MTFR2 to Regulate the Proliferation, Invasion and Migration of Colorectal Cancer Cells

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2021 Sep 15
PMID 34523692
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

HOXC10 and mitochondrial fission regulator 2 (MTFR2) have been reported to be abnormally expressed in multiple types of cancer tissues. However, the effects of HOXC10 and MTFR2 on colorectal cancer (CRC) remain poorly understood. Therefore, the present study aimed to investigate the expression of HOXC10 and MTFR2 in CRC tissues and cells, and analyze their effects on CRC cell proliferation, invasion and migration. Reverse transcription‑quantitative PCR and western blotting were used to detect the expression levels of MTFR2 and HOXC10 in tissues and cells. To investigate the association between MTFR2 and HOXC10, short hairpin RNA‑MTFR2 and overexpression vector‑HOXC10 were transfected into the cells, respectively. Furthermore, western blotting was performed to detect the expression levels of invasion‑associated proteins. The proliferation, clone formation, invasion and migration of colorectal cancer cells were in turn analyzed by the Cell Counting Kit‑8, clone formation, wound healing and Transwell assays. Japan Automotive Software Platform and Architecture software predicted the binding sites between HOXC10 and MTFR2, which was confirmed by the dual‑luciferase reporter assay and chromatin immunoprecipitation. The present study demonstrated that HOXC10 and MTFR2 mRNA and protein expression levels were significantly upregulated in CRC tissues and cells. MTFR2 knockdown significantly inhibited CRC cell proliferation, clone formation, invasion and migration. Furthermore, HOXC10 was shown to interact with MTFR2. HOXC10 overexpression was able to significantly reverse the inhibitory effects of MTFR2 knockdown on CRC cells. In conclusion, HOXC10 overexpression activated MTFR2 expression to enhance the proliferation, clone formation, invasion and migration of CRC cells.

Citing Articles

The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors.

Liu Y, Wang H, Zhang S, Peng N, Hai S, Zhao H Cancer Cell Int. 2025; 25(1):46.

PMID: 39955547 PMC: 11829463. DOI: 10.1186/s12935-025-03685-2.


The HOXC10/NOD1/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer.

Li K, Yang B, Du Y, Ding Y, Shen S, Sun Z Bone Res. 2024; 12(1):47.

PMID: 39191757 PMC: 11349752. DOI: 10.1038/s41413-024-00350-8.


Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets.

Wu Z, Xiao C, Long J, Huang W, You F, Li X Cell Commun Signal. 2024; 22(1):91.

PMID: 38302953 PMC: 10835948. DOI: 10.1186/s12964-024-01490-4.


Mitochondrial fusion-fission dynamics and its involvement in colorectal cancer.

Wu Z, Xiao C, Li F, Huang W, You F, Li X Mol Oncol. 2023; 18(5):1058-1075.

PMID: 38158734 PMC: 11076987. DOI: 10.1002/1878-0261.13578.


HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells.

Yu J, Chen X, Zhao S, Jing J, Wang Q, Dang Y J Cancer. 2022; 13(12):3308-3317.

PMID: 36186898 PMC: 9516010. DOI: 10.7150/jca.76945.


References
1.
Lu G, Lai Y, Wang T, Lin W, Lu J, Ma Y . Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. Aging (Albany NY). 2019; 11(22):10203-10219. PMC: 6914410. DOI: 10.18632/aging.102442. View

2.
Liang P, Shaukat A . Assessing the impact of lowering the colorectal cancer screening age to 45 years. Lancet Gastroenterol Hepatol. 2020; 5(6):523-524. DOI: 10.1016/S2468-1253(20)30054-6. View

3.
Wang W, Xiong M, Jiang L, Chen Z, Shao Y . MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis. Front Oncol. 2020; 10:858. PMC: 7267185. DOI: 10.3389/fonc.2020.00858. View

4.
Moran A, Iniesta P, Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A . Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer. Oncol Rep. 2004; 13(1):115-20. View

5.
Guan Y, He Y, Lv S, Hou X, Li L, Song J . Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. J Drug Target. 2018; 27(1):60-66. DOI: 10.1080/1061186X.2018.1473408. View